Only four of 307 hospitals that participated in a test of pharmacy computer systems detected 10 of 10 specific, lethal medication orders, according to the Institute for Safe Medication Practices.
Only four of 307 hospitals that participated in a test of pharmacy computer systems detected 10 of 10 specific, lethal medication orders, according to the Institute for Safe Medication Practices.
The Martinsdale, PA-based nonprofit organization tested the hospitals on lethal medication orders that were reported to the U.S. Pharmacopoeia Medication Errors Reporting Program in 1998. Although some hospitals detected many potential problems, an overwhelming number failed on at least one count.
"It's frightening to believe that the vast majority of our nation's pharmacy computer systems currently may be incapable of preventing these lethal errors," said Michael Cohen, cofounder of the Institute.
According to the Institute's survey, 87% of the tested computer systems failed to detect toxic doses of antibiotics for patients with renal impairment. Similarly, 87% failed to detect single or cumulative lethal doses of colchicine, a drug used for gout.
Sixty-five percent of the pharmacy systems did not detect potentially toxic drug ingredient duplication with acetaminophen and Percocet,® which contains acetaminophen; more than 60% failed to find lethal overdoses of the cancer drugs cisplatin or vincristine; 61% did not raise an alert when an oral suspension was ordered for intravenous use; and 58% of the systems did not link the pharmacy to the hospital laboratory so that they could share vital information.
Despite these shortcomings, the Institute noted that many of the systems can be programmed to improve drug interaction warnings. Almost 70% of those who participated in the test said their systems allowed them to program specific medication alerts based on drug information updates and error alerts.
However, computers are only as smart as their programmers tell them to be, and only 54% of test participants said they receive and integrate drug information updates into their systems on at least a quarterly basis. Another 8% said they never integrate the information. Three percent claimed they never receive the information at all.
The Institute of Safe Medication Practices recommended that hospital pharmacies seek out drug information alerts, build error alerts into existing computer screening programs and avoid sole reliance on computer screening for the detection of prescription drug errors. PR
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.